Literature DB >> 24726053

Gestational diabetes and hypertensive disorders of pregnancy as vascular risk signals: an overview and grading of the evidence.

Kara Nerenberg1, Stella S Daskalopoulou2, Kaberi Dasgupta3.   

Abstract

The occurrence of common pregnancy-related medical disorders identifies women at high risk of developing future vascular disease. Systematic reviews of cohort studies demonstrate that gestational diabetes confers a 7-fold risk increase for type 2 diabetes, and preeclampsia confers a 1.8-fold risk increase for type 2 diabetes and 3.4-fold risk increase for hypertension. Gestational diabetes and hypertensive disorders of pregnancy (HDP) increase the risk of premature vascular disease, but the 2-fold risk increase associated with preeclampsia is only partially explained by the development of traditional vascular risk factors. Despite the compelling evidence for gestational diabetes and HDP as vascular risk indicators, there are no published Canadian vascular prevention guidelines that recognize these postpartum women. In contrast, the 2011 American Heart Association guidelines on cardiovascular disease in women include gestational diabetes and HDP in their vascular risk assessment. Studies indicate that the importance surveillance of vascular risk factors in these women after pregnancy is underappreciated by the women themselves and their physicians. Although a prudent diet and physically active lifestyle were demonstrated to reduce diabetes risk in women with a gestational diabetes history in the American Diabetes Prevention Program trial, adoption of these health behaviours is low; qualitative studies confirm a need for tailored strategies that address barriers and provide social support. Further research is also needed on approaches to reduce vascular risk in women with a history of gestational diabetes and HDP. Otherwise, an early window of opportunity for chronic disease prevention in young, high-risk women will be missed.
Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24726053     DOI: 10.1016/j.cjca.2013.12.030

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  16 in total

1.  The Relationship of Restless Legs Syndrome to History of Pregnancy-Induced Hypertension.

Authors:  Kim E Innes; Sahiti Kandati; Kathryn L Flack; Parul Agarwal; Terry Kit Selfe
Journal:  J Womens Health (Larchmt)       Date:  2016-02-25       Impact factor: 2.681

Review 2.  Preventing Gestational Diabetes Mellitus by Improving Healthy Diet and/or Physical Activity during Pregnancy: An Umbrella Review.

Authors:  Malak Kouiti; Cristian Hernández-Muñiz; Ibtissam Youlyouz-Marfak; Inmaculada Salcedo-Bellido; Juan Mozas-Moreno; José Juan Jiménez-Moleón
Journal:  Nutrients       Date:  2022-05-14       Impact factor: 6.706

Review 3.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

4.  The Broken Thread of Health Promotion and Disease Prevention for Women During the Postpartum Period.

Authors:  Lorraine O Walker; Christina L Murphey; Francine Nichols
Journal:  J Perinat Educ       Date:  2015

Review 5.  Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease.

Authors:  Xin Zhou; Jian-Min Niu; Wen-Jie Ji; Zhuoli Zhang; Peizhong P Wang; Xue-Feng B Ling; Yu-Ming Li
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

6.  Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia.

Authors:  Marloes Dekker Nitert; Katherin Scholz-Romero; Marta H Kubala; H David McIntyre; Leonie K Callaway; Helen L Barrett
Journal:  Reprod Biol Endocrinol       Date:  2015-03-08       Impact factor: 5.211

7.  Preeclampsia: A risk factor for gestational diabetes mellitus in subsequent pregnancy.

Authors:  Joohyun Lee; Yung-Taek Ouh; Ki Hoon Ahn; Soon Cheol Hong; Min-Jeong Oh; Hai-Joong Kim; Geum Joon Cho
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

8.  Pre-Conception Dyslipidemia Is Associated with Development of Preeclampsia and Gestational Diabetes Mellitus.

Authors:  Yael Baumfeld; Lena Novack; Arnon Wiznitzer; Eyal Sheiner; Yakov Henkin; Michael Sherf; Victor Novack
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

9.  Fish Oil Supplementation does not Reduce Risks of Gestational Diabetes Mellitus, Pregnancy-Induced Hypertension, or Pre-Eclampsia: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Bing Chen; Xinran Ji; Lei Zhang; Zhaohui Hou; Chundong Li; Ying Tong
Journal:  Med Sci Monit       Date:  2015-08-09

Review 10.  Evidences of Polymorphism Associated with Circadian System and Risk of Pathologies: A Review of the Literature.

Authors:  F J Valenzuela; J Vera; C Venegas; S Muñoz; S Oyarce; K Muñoz; C Lagunas
Journal:  Int J Endocrinol       Date:  2016-05-22       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.